177 related articles for article (PubMed ID: 16780590)
1. The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer.
Mitra AP; Almal AA; George B; Fry DW; Lenehan PF; Pagliarulo V; Cote RJ; Datar RH; Worzel WP
BMC Cancer; 2006 Jun; 6():159. PubMed ID: 16780590
[TBL] [Abstract][Full Text] [Related]
2. Use of Artificial Intelligence and Machine Learning Algorithms with Gene Expression Profiling to Predict Recurrent Nonmuscle Invasive Urothelial Carcinoma of the Bladder.
Bartsch G; Mitra AP; Mitra SA; Almal AA; Steven KE; Skinner DG; Fry DW; Lenehan PF; Worzel WP; Cote RJ
J Urol; 2016 Feb; 195(2):493-8. PubMed ID: 26459038
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profile of primary gastric cancer: towards the prediction of lymph node status.
Marchet A; Mocellin S; Belluco C; Ambrosi A; DeMarchi F; Mammano E; Digito M; Leon A; D'Arrigo A; Lise M; Nitti D
Ann Surg Oncol; 2007 Mar; 14(3):1058-64. PubMed ID: 17106627
[TBL] [Abstract][Full Text] [Related]
4. Introducing a novel and robust technique for determining lymph node status in colorectal cancer.
Hogan J; Judge C; O'Callaghan M; Aziz A; O'Connor C; Burke J; Dunne C; Walsh S; Kalady M; Coffey JC
Ann Surg; 2014 Jul; 260(1):94-102. PubMed ID: 24169164
[TBL] [Abstract][Full Text] [Related]
5. Microarray gene-expression profiling to predict lymph node metastasis in penile carcinoma.
Kroon BK; Leijte JA; van Boven H; Wessels LF; Velds A; Horenblas S; van't Veer LJ
BJU Int; 2008 Aug; 102(4):510-5. PubMed ID: 18476970
[TBL] [Abstract][Full Text] [Related]
6. Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.
Fleischmann A; Rotzer D; Seiler R; Studer UE; Thalmann GN
Eur Urol; 2011 Aug; 60(2):350-7. PubMed ID: 21640482
[TBL] [Abstract][Full Text] [Related]
7. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.
Sanchez-Carbayo M; Socci ND; Lozano J; Saint F; Cordon-Cardo C
J Clin Oncol; 2006 Feb; 24(5):778-89. PubMed ID: 16432078
[TBL] [Abstract][Full Text] [Related]
8. Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer.
Tamoto E; Tada M; Murakawa K; Takada M; Shindo G; Teramoto K; Matsunaga A; Komuro K; Kanai M; Kawakami A; Fujiwara Y; Kobayashi N; Shirata K; Nishimura N; Okushiba S; Kondo S; Hamada J; Yoshiki T; Moriuchi T; Katoh H
Clin Cancer Res; 2004 Jun; 10(11):3629-38. PubMed ID: 15173069
[TBL] [Abstract][Full Text] [Related]
9. Prediction of lymph node metastasis by analysis of gene expression profiles in primary lung adenocarcinomas.
Xi L; Lyons-Weiler J; Coello MC; Huang X; Gooding WE; Luketich JD; Godfrey TE
Clin Cancer Res; 2005 Jun; 11(11):4128-35. PubMed ID: 15930348
[TBL] [Abstract][Full Text] [Related]
10. Nodal staging score: a tool for survival prediction of node-negative bladder cancer.
Ku JH; Kim HH; Kwak C
Urol Oncol; 2013 Nov; 31(8):1731-6. PubMed ID: 23141779
[TBL] [Abstract][Full Text] [Related]
11. Detection of occult tumor cells in lymph nodes from bladder cancer patients by MUC7 nested RT-PCR.
Retz M; Lehmann J; Szysnik C; Zwank S; Venzke T; Röder C; Kalthoff H; Basbaum C; Stöckle M
Eur Urol; 2004 Mar; 45(3):314-9. PubMed ID: 15036676
[TBL] [Abstract][Full Text] [Related]
12. Molecular determination of perivesical and lymph node metastasis after radical cystectomy for urothelial carcinoma of the bladder.
Seraj MJ; Thomas AR; Chin JL; Theodorescu D
Clin Cancer Res; 2001 Jun; 7(6):1516-22. PubMed ID: 11410485
[TBL] [Abstract][Full Text] [Related]
13. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
Deserno WM; Harisinghani MG; Taupitz M; Jager GJ; Witjes JA; Mulders PF; Hulsbergen van de Kaa CA; Kaufmann D; Barentsz JO
Radiology; 2004 Nov; 233(2):449-56. PubMed ID: 15375228
[TBL] [Abstract][Full Text] [Related]
14. Clonal origin of lymph node metastases in bladder carcinoma.
Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
[TBL] [Abstract][Full Text] [Related]
15. External validation of extranodal extension and lymph node density as predictors of survival in node-positive bladder cancer after radical cystectomy.
Masson-Lecomte A; Vordos D; Hoznek A; Yiou R; Allory Y; Abbou CC; de la Taille A; Salomon L
Ann Surg Oncol; 2013 Apr; 20(4):1389-94. PubMed ID: 23208127
[TBL] [Abstract][Full Text] [Related]
16. Gene expression in early stage cervical cancer.
Biewenga P; Buist MR; Moerland PD; Ver Loren van Themaat E; van Kampen AH; ten Kate FJ; Baas F
Gynecol Oncol; 2008 Mar; 108(3):520-6. PubMed ID: 18191186
[TBL] [Abstract][Full Text] [Related]
17. Four-gene expression model predictive of lymph node metastases in oral squamous cell carcinoma.
Pasini FS; Maistro S; Snitcovsky I; Barbeta LP; Rotea Mangone FR; Lehn CN; Walder F; Carvalho MB; Brentani MM; Federico MH
Acta Oncol; 2012 Jan; 51(1):77-85. PubMed ID: 21985131
[TBL] [Abstract][Full Text] [Related]
18. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
Mills RD; Turner WH; Fleischmann A; Markwalder R; Thalmann GN; Studer UE
J Urol; 2001 Jul; 166(1):19-23. PubMed ID: 11435814
[TBL] [Abstract][Full Text] [Related]
19. Prediction of lymph node metastasis using the combined criteria of helical CT and mRNA expression profiling for non-small cell lung cancer.
Chang JW; Yi CA; Son DS; Choi N; Lee J; Kim HK; Choi YS; Lee KS; Kim J
Lung Cancer; 2008 May; 60(2):264-70. PubMed ID: 18280003
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinoma.
Copp HL; Chin JL; Conaway M; Theodorescu D
Cancer; 2006 Jul; 107(1):60-6. PubMed ID: 16691580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]